Top Markets
#1 CyberDEX CyberDEX +372.54%
#2 OVERTAKE OVERTAKE +56.57%
#3 ALEO ALEO +43.43%
#4 Nillion Nillion +34.21%
#5 Clearpool Clearpool +27.85%
#6 Playnance Playnance +23.56%
#7 deBridge deBridge +23.20%
#8 龙虾 (Lobster) 龙虾 (Lobster) +19.17%
#9 AUKI AUKI +18.69%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.88%
Coin of the day
CyberDEX CyberDEX
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Intellipharmaceutics International Inc. Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc.

IPCI
Pozycja w akcjach #37499
Intellipharmaceutics International Inc., founded in Toronto, Canada, in 1998,... Intellipharmaceutics International Inc., founded in Toronto, Canada, in 1998, is a pharmaceutical company that focuses on the research, development, and manufacturing of innovative and generic controlled-release and targeted-release oral solid dosage medications, primarily for the United States market. The company leverages its patented Hypermatrix technology to create advanced drug delivery systems, an array of product candidates, and a robust pipeline across diverse therapeutic areas, including neurological, cardiovascular, gastrointestinal, diabetes, and pain management conditions. Its current product portfolio includes extended-release formulations like Focalin XR for hyperactivity disorder, Keppra XR for partial onset seizures, Effexor XR to treat depression, and Protonix for gastroesophageal reflux disease. Other offerings feature Glucophage XR for type 2 diabetes, Seroquel XR for schizophrenia and mood disorders, Lamictal XR for epilepsy, Pristiq for depression, Coreg CR for heart failure and hypertension, and Ranexa for chronic angina. Furthermore, Intellipharmaceutics is actively developing additional controlled-release drugs such as OxyContin for pain relief and Regabatin XR for neuropathic pain management. The company operates under a license and commercialization agreement with Par Pharmaceutical Inc.
Cena akcji
$0.05897422
Ostatnia synchronizacja: 2024-04-02
Kapitalizacja rynkowa
$1.64M
Zmiana (1 dzień)
0.07%
Zmiana (1 rok)
-60.68%
Kraj
CA
Handel Intellipharmaceutics International Inc. (IPCI)

Kategoria

Healthcare
Liczba akcji w obrocie dla Intellipharmaceutics International Inc. (IPCI)
Liczba akcji w obrocie na dzień August 2023: 33.09M
Zgodnie z najnowszymi raportami finansowymi i ceną akcji Intellipharmaceutics International Inc., aktualna liczba akcji w obrocie to 33.09M. Na koniec November 2021 firma posiadała 29.43M akcji w obrocie. Liczba akcji w obrocie jest zwykle kształtowana przez podziały akcji i skupy akcji.
Historia liczby akcji w obrocie dla Intellipharmaceutics International Inc. (IPCI) od 1999 do 2026
Akcje w obrocie na koniec każdego roku
Rok Akcje w obrocie Zmień
2026 (TTM) 33.09M 0.00%
2022 33.09M 12.45%
2021 29.43M 24.90%
2020 23.56M 9.18%
2019 21.58M 353.15%
2018 4.76M 53.55%
2017 3.10M 16.16%
2016 2.67M 12.34%
2015 2.38M 3.11%
2014 2.31M 17.18%
2013 1.97M 13.98%
2012 1.73M 15.10%
2011 1.50M 37.47%
2010 1.09M -51.30%
2008 2.24M 13.63%
2007 1.97M 124.16%
2006 879.29K 10.85%
2005 793.22K 15.41%
2004 687.29K 11.69%
2003 615.38K 27.29%
2002 483.46K 7.69%
2001 448.93K 2.77%
2000 436.82K 49.40%
1999 292.38K 0.00%
Akcje w obrocie dla podobnych firm lub konkurentów
Firma Akcje w obrocie Różnica Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 667.24%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 1,096.64%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 1,347.18%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 87.91%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH